Showing 101 - 120 results of 132 for search '"Umeå University"', query time: 0.06s Refine Results
  1. 101

    Sequence Analysis of How Disability Influenced Life Trajectories in a Past Population from the Nineteenth-Century Sundsvall Region, Sweden by Lotta Vikström, Helena Haage, Erling Häggström Lundevaller

    Published 2017-05-01
    “…Having access to micro-data that report disabilities in a population of 8,874 individuals from the parish registers digitised by the Demographic Data Base, Umeå University, we employ sequence analysis on a series of events that are expected to occur in life of young adults: getting a job, marrying and becoming a parent, while also taking into account out-migration and death. …”
    Get full text
    Article
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116

    Chronic Airflow Limitation, Lower Respiratory Symptoms, COPD and Chronic Rhinosinusitis in a Middle-Aged Population: The Swedish CArdioPulmonary bioImage Study (SCAPIS). A Link Bet... by Andersson A, Bergqvist J, Schiöler L, Bossios A, Farnebo L, Holmlund T, Janson C, Keceli S, Ljunggren M, Malinovschi A, Memarian E, Nihlén U, Nilsson PM, Pesonen I, Sjöström M, Stenfors N, Sundbom F, Werner M, Torén K, Sköld M, Hellgren J

    Published 2025-02-01
    “…Anders Andersson,1,2,* Joel Bergqvist,3,4,* Linus Schiöler,5 Apostolos Bossios,6,7 Lovisa Farnebo,8,9 Thorbjörn Holmlund,10 Christer Janson,11 Sumru Keceli,12 Mirjam Ljunggren,11 Andrei Malinovschi,13 Ensieh Memarian,14 Ulf Nihlén,15 Peter M Nilsson,16,17 Ida Pesonen,18,19 Marcus Sjöström,10 Nikolai Stenfors,20 Fredrik Sundbom,11 Mimmi Werner,10 Kjell Torén,5,21 Magnus Sköld,22,23 Johan Hellgren24,25 1COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden; 2COPD Center, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 3Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden; 4Centre for Sleep and Wake Disorders, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Occupational and Environmental Medicine, School of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 6Karolinska Severe Asthma Center, Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; 7Division of Lung and Airway Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; 8Linköping University Faculty of Medicine and Health Sciences, Department of Biomedical and Clinical Sciences, Division of Sensory Organs and Communication, Linköping, Sweden; 9Region Östergötland, Anaesthetics, Operations and Specialty Surgery Center, Department of Otorhinolaryngology, Linköping, Sweden; 10Department of Clinical Sciences, Otorhinolaryngology, Umeå University, Umeå, Sweden; 11Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; 12Department of Otorhinolaryngology in Linköping, Region Östergötland, Linköping, Sweden; 13Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden; 14Department of Clinical Sciences, IKVM, Internal Medicine, Lund University, Malmö, Sweden; 15Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden; 16Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden; 17Clinical Research Unit, Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden; 18Respiratory Medicine Unit, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden; 19Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Stockholm, Sweden; 20Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden; 21Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden; 22Department of Respiratory Medicine and Allergy, Karolinska University Hospital Solna, Stockholm, Sweden; 23Respiratory Medicine Unit, Department of Medicine Solna and Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; 24Department of Otorhinolaryngology, Head & Neck Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden; 25Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden*These authors contributed equally to this workCorrespondence: Anders Andersson, COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Bruna Stråket 11B, Göteborg, 413 46, Sweden, Email Anders.Andersson@lungall.gu.sePurpose: Chronic rhinosinusitis (CRS) is related to asthma and chronic obstructive pulmonary disease (COPD). …”
    Get full text
    Article
  17. 117
  18. 118
  19. 119

    Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population by Erik Håkansson, Helena Norberg, Sara Själander, Krister Lindmark

    Published 2021-01-01
    “…Medical records of all heart failure patients who had a diagnosis of heart failure from the Heart Centre or Department of Internal Medicine at Umeå University Hospital were reviewed. Results. 2433 of the hospital’s uptake population of 150 000 had a diagnosis of heart failure. 681 patients had left ventricle ejection fraction≤40%, and of these 352 (52%) and 268 (39%) patients met eligibility criteria for DAPA-HF and EMPEROR-reduced, respectively. …”
    Get full text
    Article
  20. 120